Published in Clin Exp Immunol on December 01, 2011
Macrophage heterogeneity in respiratory diseases. Mediators Inflamm (2013) 1.20
IL-1R signalling is critical for regulation of multi-walled carbon nanotubes-induced acute lung inflammation in C57Bl/6 mice. Nanotoxicology (2012) 1.04
The genetic basis of idiopathic pulmonary fibrosis. Eur Respir J (2015) 0.91
IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study. Immunogenetics (2012) 0.90
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediators Inflamm (2015) 0.89
Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis. Arthritis Res Ther (2017) 0.84
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin Immunopathol (2016) 0.83
Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis. Int J Mol Epidemiol Genet (2014) 0.76
Pharmacogenetics and interstitial lung disease. Curr Opin Pulm Med (2016) 0.75
Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs. Biomed Res Int (2015) 0.75
Efficiency and power in genetic association studies. Nat Genet (2005) 25.56
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest (2001) 3.72
IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest (2007) 2.88
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax (2006) 2.59
Interleukin-1 receptor antagonist. Adv Immunol (1993) 2.58
Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine (1993) 2.48
The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol (2007) 2.22
Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2002) 2.08
Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am J Cardiol (2010) 1.82
Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med (2000) 1.68
British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival. Thorax (2006) 1.39
Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax (1998) 1.29
Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol (1994) 1.25
Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2002) 1.22
Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2001) 1.16
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol (2004) 1.14
Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2002) 1.09
Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum Genet (1996) 1.02
Cytokine gene polymorphisms in idiopathic pulmonary fibrosis. Intern Med J (2004) 0.95
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs. Am J Physiol Lung Cell Mol Physiol (2004) 0.95
Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol (1998) 0.93
Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis (1997) 0.89
Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol (2008) 0.86
Generation of a transgenic mouse with lung-specific overexpression of the human interleukin-1 receptor antagonist protein. Am J Respir Cell Mol Biol (1998) 0.85
Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis. Ann Rheum Dis (1995) 0.84
Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun (2004) 0.83
Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet (1999) 3.35
Racial inequality in active life among adult Americans. Demography (1999) 2.02
Reduced local immune response with continuous positive airway pressure during one-lung ventilation for oesophagectomy. Br J Anaesth (2014) 1.98
Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy (2009) 1.84
Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol (2003) 1.82
Biomarker reproducibility in exhaled breath condensate collected with different condensers. Eur Respir J (2008) 1.70
Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax (2006) 1.60
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J (2006) 1.56
Pneumococcal polysaccharides induce antibody formation by human B lymphocytes in vitro. J Immunol (1985) 1.55
Nocardiosis: a case series and a mini review of clinical and microbiological features. Neth J Med (2007) 1.54
Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology. Eur Respir J (2005) 1.48
The importance of hand anatomy in the accident and emergency department: assessment of hand anatomy knowledge in doctors in training. J Hand Surg Eur Vol (2009) 1.48
Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet (1991) 1.45
Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect Immun (1991) 1.42
Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis. J Pediatr (1994) 1.40
Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial. Respir Res (2009) 1.34
Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy (2005) 1.31
Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol (2008) 1.30
Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Clin Infect Dis (2001) 1.29
Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest (2000) 1.26
Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis (1994) 1.25
Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun (1995) 1.24
A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. J Immunol (1991) 1.19
Systemic cytokine response in patients with community-acquired pneumonia. Eur Respir J (2010) 1.19
Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am J Pathol (1990) 1.14
Corticosteroid treatment in sarcoidosis. Eur Respir J (2006) 1.13
Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr Res (1993) 1.11
Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin Exp Immunol (2007) 1.10
Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods (1992) 1.09
The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum (2003) 1.09
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis (2011) 1.07
Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun (2003) 1.07
Human C-reactive protein does not bind to FcgammaRIIa on phagocytic cells. J Clin Invest (2001) 1.07
Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2012) 1.07
The role of airway epithelium and blood neutrophils in the inflammatory response in cystic fibrosis. J Cyst Fibros (2005) 1.05
Atopy and new-onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case-control study. Clin Exp Allergy (2007) 1.04
Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest (1995) 1.04
Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect Immun (1991) 1.03
Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses. Clin Vaccine Immunol (2006) 1.02
Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2009) 1.02
Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine. Vaccine (2008) 1.01
Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum (1996) 1.01
Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication. Clin Exp Immunol (1997) 1.00
The immune response in adenoids and tonsils. Int Arch Allergy Immunol (2000) 1.00
Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford) (2003) 1.00
Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET. Q J Nucl Med Mol Imaging (2011) 1.00
Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J Allergy Clin Immunol (1993) 0.99
The immune system of cyprinid fish. Oxytetracycline and the regulation of humoral immunity in carp (Cyprinus carpio). Vet Immunol Immunopathol (1981) 0.99
Variation in IL7R predisposes to sarcoid inflammation. Genes Immun (2009) 0.98
Immunologic studies in Turner syndrome before and during treatment with growth hormone. The Dutch Growth Hormone Working Group. J Pediatr (1991) 0.98
Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. J Immunol (1990) 0.98
Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines. Scand J Immunol (2005) 0.97
Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes. Clin Exp Immunol (2009) 0.97
Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res (2009) 0.97
Prediction of asthma exacerbations in children: results of a one-year prospective study. Clin Exp Allergy (2012) 0.96
Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes. J Exp Med (1995) 0.95
Expression and functional characteristics of the complement receptor type 2 on adult and neonatal B lymphocytes. Clin Immunol Immunopathol (1993) 0.95
The effects of commonly used resuscitation fluids on whole blood coagulation. Emerg Med J (2006) 0.94
Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol (2007) 0.94
Fcgamma receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera. J Infect Dis (1999) 0.94
Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens (2007) 0.93
Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia. J Clin Immunol (1999) 0.93
Ex vivo cytokine release reflects sensitivity to occupational endotoxin exposure. Eur Respir J (2009) 0.92
Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine. Clin Exp Immunol (1999) 0.92
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections. AIDS (1998) 0.92
Bronchoalveolar lavage cell pattern from healthy human lung. Clin Exp Immunol (2012) 0.92
Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clin Exp Allergy (2010) 0.92
Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue Antigens (2012) 0.92
Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine (2001) 0.91
Treatment with anti-inflammatory drugs in community-acquired pneumonia. J Intern Med (2012) 0.91
Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients. Clin Exp Immunol (2006) 0.90
The immune system of cyprinid fish. Kinetics and temperature dependence of antibody-producing cells in carp (Cyprinus carpio). Immunology (1980) 0.90